Document is current
Any future updates will be listed below
-
Authors
Gross, Sean M.
Dane, Mark A. https://orcid.org/0000-0003-3742-9866
Smith, Rebecca L.
Devlin, Kaylyn L.
McLean, Ian C. https://orcid.org/0000-0003-2741-7941
Derrick, Daniel S.
Mills, Caitlin E. https://orcid.org/0000-0002-2608-4084
Subramanian, Kartik
London, Alexandra B.
Torre, Denis
Evangelista, John Erol
Clarke, Daniel J. B.
Xie, Zhuorui
Erdem, Cemal https://orcid.org/0000-0003-3663-3646
Lyons, Nicholas
Natoli, Ted
Pessa, Sarah
Lu, Xiaodong
Mullahoo, James
Li, Jonathan
Adam, Miriam
Wassie, Brook
Liu, Moqing
Kilburn, David F.
Liby, Tiera A.
Bucher, Elmar https://orcid.org/0000-0002-2929-2460
Sanchez-Aguila, Crystal
Daily, Kenneth
Omberg, Larsson
Wang, Yunguan
Jacobson, Connor
Yapp, Clarence
Chung, Mirra
Vidovic, Dusica
Lu, Yiling
Schurer, Stephan https://orcid.org/0000-0001-7180-0978
Lee, Albert
Pillai, Ajay
Subramanian, Aravind
Papanastasiou, Malvina https://orcid.org/0000-0003-3378-6612
Fraenkel, Ernest https://orcid.org/0000-0001-9249-8181
Feiler, Heidi S. https://orcid.org/0000-0002-6580-3547
Mills, Gordon B.
Jaffe, Jake D. https://orcid.org/0000-0001-9845-1210
Ma’ayan, Avi
Birtwistle, Marc R.
Sorger, Peter K. https://orcid.org/0000-0002-3364-1838
Korkola, James E.
Gray, Joe W.
Heiser, Laura M. https://orcid.org/0000-0003-3330-0950
- License Information
-
More Information
Article History
Received: 5 August 2021
Accepted: 12 September 2022
First Online: 7 October 2022
Competing interests
: The authors declare the following competing interests: G.B.M. SAB/Consultant: Abbvie, AstraZeneca, Chrysallis Biotechnology, GSK, Ellipses Pharma, ImmunoMET, Infinity, Ionis, Lilly, Medacorp, Nanonstring, PDX Pharmaceuticals, Signalchem Lifesciences, Symphogen, Tarveda, Turbine, Zentalis Pharmaceuticals. Stock/Options/Financial: Catena Pharmaceuticals, ImmunoMet, SignalChem, Tarveda, Turbine. Licensed Technology: HRD assay to Myriad Genetics, DSP patents with Nanostring. J.W.G. has licensed technologies to Abbott Diagnostics and PDX Pharmaceuticals; has ownership positions in Convergent Genomics, Health Technology Innovations, and PDX Pharmaceuticals; serves as a paid consultant to New Leaf Ventures; has received research support from Thermo Fisher Scientific (formerly FEI), Zeiss, Miltenyi Biotech, Quantitative Imaging, Health Technology Innovations and Micron Technologies; and owns stock in Abbott Diagnostics, AbbVie, Alphabet, Amazon, AMD, Amgen, Apple, Berkshire, Cisco systems, Clorox, Colgate Palmolive, Crown Castle Int., Humana, Keysight, Linde, Proctor and Gamble, Qualcomm, Unilever, Gilead, Intel, Johnson & Johnson, Microsoft, Nvidia, Taiwan Semiconductor, and Zimmer Biomet.
